Bmc Gastroenterology
Overview
BMC Gastroenterology is an open-access journal that publishes high-quality research articles, reviews, and case reports in all areas of gastroenterology and hepatology. It covers a wide range of topics including gastrointestinal diseases, liver disorders, digestive system cancers, endoscopy, and therapeutic interventions. The journal aims to provide a platform for researchers and clinicians to share their findings and advancements in the field of gastroenterology.
Details
Details
Abbr.
BMC Gastroenterol
Publisher
Biomed Central
Start
2001
End
Continuing
e-ISSN
1471-230X
Country
United Kingdom
Language
English
Specialty
Gastroenterology
Metrics
Metrics
h-index / Ranks: 3490
93
SJR / Ranks: 5816
747
CiteScore / Ranks: 6878
3.90
JIF / Ranks: 4480
2.4
Recent Articles
1.
Zhang W, Kang N, Wang Y, Zhang F, Xue J, Linghu E
BMC Gastroenterol
. 2025 Mar;
25(1):176.
PMID: 40089662
Background: In this survey, we compared endoscopists' approach to treatment of gastroesophageal varices (GOV) in patients with cirrhosis between developed and developing countries. The objective of this study was to...
2.
Liu S, Hu L, Zhang X
BMC Gastroenterol
. 2025 Mar;
25(1):175.
PMID: 40087580
Purpose: This study aimed to explore the clinical factors associated with lymph node metastasis (LNM) and survival in T2 colon cancer. Method: Patients with T2 colon cancer and receiving radical...
3.
Luo M, Dai Y, Feng X, Wang Y, Guo X, Du J, et al.
BMC Gastroenterol
. 2025 Mar;
25(1):174.
PMID: 40087578
Background: The RCT study on the efficacy of continuous active warming (CAW) in patients undergoing laparoscopic gastrectomy is scarce. The purpose of this research was to determine if a significant...
4.
Ji X, Wang G, Pan D, Xu S, Lei X
BMC Gastroenterol
. 2025 Mar;
25(1):173.
PMID: 40087572
Background: Pembrolizumab, a PD-1 inhibitor, has shown potential for treating advanced gastric and gastroesophageal junction (GEJ) cancer. This meta-analysis evaluates its efficacy and safety, alone or combined with chemotherapy, in...
5.
Jiang S, Zhang F, Yang H, Han X, Mao J, Zheng G, et al.
BMC Gastroenterol
. 2025 Mar;
25(1):168.
PMID: 40082781
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide. However, there is a lack of cost-effective and accurate biomarkers to assess the degree of...
6.
Deng L, Huang J, Yuan H, Liu Q, Lou W, Yu P, et al.
BMC Gastroenterol
. 2025 Mar;
25(1):172.
PMID: 40082778
Background: The objective was to develop a biological age prediction model (NC-BA) for the Chinese population to enrich the relevant studies in this population. And to investigate the association between...
7.
Amlashi F, Besharat S, Jahanshahi M, Shirzad-Aski H, Torshizi F
BMC Gastroenterol
. 2025 Mar;
25(1):171.
PMID: 40082771
Background And Aim: Hyperalgesia and hypersensitivity in patients with Inflammatory Bowel Disease (IBD) can be related to central nervous system (CNS) changes, particularly in the pain pathways. The objective of...
8.
Jahn B, Bundo M, Arvandi M, Schaffner M, Todorovic J, Sroczynski G, et al.
BMC Gastroenterol
. 2025 Mar;
25(1):170.
PMID: 40082770
Background: White light (conventional) colonoscopy (WLC) is widely used for colorectal cancer screening, diagnosis and surveillance but endoscopists may fail to detect adenomas. Our goal was to assess and synthesize...
9.
Deng Y, Chen Z, He Q, Wu B, Su T, Mao C, et al.
BMC Gastroenterol
. 2025 Mar;
25(1):169.
PMID: 40082749
Background: Primary liver cancer is a highly aggressive neoplasm with high incidence and mortality. Due to the high ability to metastasis, the 5-year survival rate of patients with primary liver...
10.
Zheng C, Qi Z, Chen R, Liao Z, Xie L, Zhang F
BMC Gastroenterol
. 2025 Mar;
25(1):163.
PMID: 40075346
Background: Imbalance in the gut microbiota is a key factor in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis. The Dietary Index for Gut Microbiota (DI-GM) integrates...